BMPR2 has been a significant focus of experimental and human PAH over the past several years; however, the signaling of vascular endothelial growth factor (VEGF) and its effects on abnormal angiogenesis is also gaining increasing recognition. This evidence concerns the gene VEGFA and pulmonary arterial hypertension.